Dangerous Diabetes Drugs: Actos
Novo Nordisk Seeks New Uses for Victoza
Novo Nordisk’s Chief Science Officer Mads Krogsgaard Thomsen stated that the pharmaceutical company is looking into continuing trials to determine if Victoza could be marketed as a possible Alzheimer’s treatment. Victoza is currently going through a proof of concept study. If this is successful, the drug will continue through phase III clinical trials to see…
Judge Tosses Jury’s Verdict Against Actos Manufacturer Takeda
In Maryland, a jury found drug giant Takeda Pharmaceutical Company liable for $1.7 million in damages for not properly warning its user regarding the risks of taking Actos and developing bladder cancer or heart problems. The subject of the case was a deceased man by the name of Diep An, who was a former U.S….
The FDA’s Actos Warnings
The FDA has looked into the side effects of Actos several times, and though they have required the manufacturer to update its label, Actos still remains on the market. However, because patients who have suffered are standing up and forcing Takeda and Eli Lilly to be held accountable, the once hidden side effects of…
Avandia and Actos Linked to Macular Edema
Avandia and Actos both belong to the same class of Type 2 Diabetes treatments: Thiazolidinediones. Avandia has been the subject of intense scrutiny after it came to light that it can cause serious cardiovascular side effects. The FDA has severely restricted the use of Avandia. Actos has also had its share of complications, being linked…
Actos and Bladder Cancer
Actos is a treatment for Type 2 diabetes that is in a class of drugs called Thiazolidinediones. Actos lowers the amount of sugar released by the liver and makes fat cells more sensitive to the effects of insulin. Avandia, Actos’s sister drug in this same class, became a blockbuster drug before serious heart problems were…
